Cholecystokinin-B/gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies
References (66)
- et al.
Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin
Lancet
(1989) - et al.
Yttrium-90-labelled somatostatin-analogue for cancer treatment
Lancet
(1998) - et al.
The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: A clinical phase II study
Ann Oncol
(2001) - et al.
Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth
J Biol Chem
(2000) - et al.
Glycine-extended gastrin promotes the invasiveness of human colon cancer cells
Biochem Biophys Res Commun
(2001) - et al.
High density of somatostatin receptors in pituitary tumors from acromegalic patients
J Clin Endocrinol Metab
(1984) - et al.
Diagnostic applications of radiolabeled peptides in nuclear endocrinology
Q J Nucl Med
(1999) - et al.
Imaging tumors with peptide-based radioligands
Q J Nucl Med
(2001) - et al.
Radioimmunotherapy of solid tumors: A review “Of Mice and Men”
Hybridoma
(1997) Regulatory peptide receptors as molecular targets for cancer diagnosis and therapy
Q J Nucl Med
(1997)
Neuropeptide receptors in health and disease: The molecular basis for in vivo imaging
J Nucl Med
(1995)
Potential role of somatostatin analogues in the treatment of cancer
Eur J Clin Invest
(1987)
Somatostatin receptor scintigraphy
Somatostatin-receptor imaging in the localization of endocrine tumors
N Engl J Med
(1990)
Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: The Rotterdam experience with more than 1000 patients
Eur J Nucl Med
(1993)
Somatostatin-receptor scintigraphy in gastro-enteropancreatic tumors. An overview of European results
Ann N Y Acad Sci
(1994)
A comparison of 111In-octreotide and 67Ga scintigraphy in malignant lymphoma
Nucl Med Commun
(1997)
Somatostatin receptor scintigraphy in the staging of lymphomas
Leuk Lymphoma
(1997)
Anticarcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: Are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?
Cancer
(1997)
Somatostatin receptor scintigraphy in the staging of small cell lung cancer
Nucl Med Commun
(1996)
Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors
N Engl J Med
(1994)
Substance P receptors in human primary neoplasms
Int J Cancer
(1995)
Visualization of the thymus by substance P receptor scintigraphy in man
Eur J Nucl Med
(1996)
Somatostatin receptor-mediated imaging and therapy: Basic science, current knowledge, limitations and future perspectives
Eur J Nucl Med
(2001)
Therapeutic use of radiolabelled peptides
Ann Oncol
(2000)
DOTA-lanreotide: A novel somatostatin analog for tumor diagnosis and therapy
Endocrinology
(1999)
Recptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide
Eur J Nucl Med
(2001)
Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives
Cancer Res
(1995)
Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo
J Nucl Med
(1996)
Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: Present status, future prospects and limitations
Eur J Nucl Med
(1998)
Imaging in meduallary thyroid cancer
Medullary (solid) carcinoma of the thyroid: A clinicopathological entity
J Clin Endocrinol Metab
(1959)
The calcitonin secreting C cells and their relationship to the APUD cell series
J Endocrinol
(1969)
Cited by (0)
Copyright © 2002 Published by Elsevier Inc.